The European Investment Bank (EIB) will advise Antibiotice, Romania's largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.
Polish pharmaceutical company Zakłady Farmaceutyczne Polpharma has agreed to launch a voluntary public takeover offer (VTO) for all shares of Romanian drugmaker Biofarm, according to a regulatory filing.
Romania's pharmaceutical sector demonstrates resilience despite fiscal consolidation and slowing economic growth, according to Allianz Trade's latest analysis.
Cushman & Wakefield Echinox has been appointed to sell Joyson Safety Systems' industrial property in Ribiţa, Hunedoara County, as the automotive safety components manufacturer consolidates operations at its Arad hub.
Romanian authorities are making over €8 billion available this summer in EU funds and state aid for businesses and local public authorities, according to REI analysis, a consultancy group specialising in attracting non-reimbursable financing.
The National Road Investment Company (CNIR) has capitalised on European financial frameworks by signing the first two infrastructure contracts for the A8 Unirii (Union) Motorway.
Christian Tour, one of Romania's largest tour operators, has successfully completed its initial public offering (IPO), ahead of its listing on the BVB.
A Russian Geran-2 combat drone breached Romanian airspace and crashed into a residential apartment block in the eastern city of Galați early on 29 May, intensifying security concerns along NATO's eastern flank.